RACGP responds to aged care medication reform While generally supportive of the performance outcomes and role of onsite pharmacists, the college says gaps remain in the framework.
Global diabetes cases to reach 1.3 billion by 2050: Study There are countries where as many as one in five people could be living with diabetes if current trends continue.
GlucaGen Hypokit in short supply until October Another diabetes medication is now facing supply issues, adding to worldwide shortages of semaglutide and dulaglutide.
How should GPs discuss weight with their patients? A high-profile body image advocate wants doctors to stop raising the issue, but clinicians say there are ways to sensitively approach the topic.
Pharmacy green light for insulin swap due to shortage Pharmacists have been given permission to substitute a type of insulin pen due to ongoing supply issues that will likely last well into 2024.
GPs key for equitable access to glucose monitors: RACGP An ongoing NDSS review has sparked renewed calls to allow GPs to certify patients with diabetes for access to subsidised continuous glucose monitors.
‘A major public health crisis’: Diabetes policy under scrutiny Could a new Parliamentary Inquiry help address gaps in knowledge about the disease, as well as improve policy?
Lower birthweight an independent risk factor for T2D: Study It is also linked to diagnosis at a younger age, a lower prevalence of overweight/obesity, and fewer family members with a history of diabetes.
RACGP opposes GLP-1 RA prescribing restrictions Changing the authority type for initiating the diabetes medication will make it difficult for ‘already burdened’ GPs to negotiate, the PBS has been told.
GLP-1 RA prescribing checks flagged GPs may soon need Services Australia approval prior to prescribing the diabetes medications, following evidence of ‘high use’ outside of PBS restrictions.